{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:12:15Z","timestamp":1792044735129,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.coph.2022.102200","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T15:49:12Z","timestamp":1646754552000},"page":"102200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive\/therapeutic strategies"],"prefix":"10.1016","volume":"63","author":[{"given":"Virginia","family":"Protto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya Timotey","family":"Miteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica Donatella","family":"Li Puma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Teresa","family":"Palamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"De Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2022.102200_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2022.102200_bib2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.tim.2020.03.003","article-title":"Herpes simplex virus-1 in the brain: the dark side of a sneaky infection","volume":"28","author":"Marcocci","year":"2020","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coph.2022.102200_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.48.4.297","article-title":"The limbic system and the localisation of herpes simplex encephalitis","volume":"48","author":"Damasio","year":"1985","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.coph.2022.102200_bib4","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.mayocp.2012.06.023","article-title":"Herpes simplex encephalitis affecting the entire limbic system","volume":"87","author":"Sokolov","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.coph.2022.102200_bib5","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1073\/pnas.78.10.6461","article-title":"Herpes simplex type 1 DNA in human brain tissue","volume":"78","author":"Fraser","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102200_bib6","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1128\/JVI.01232-06","article-title":"Efficient reactivation of latent herpes simplex virus from mouse central nervous system tissues","volume":"80","author":"Chen","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.coph.2022.102200_sref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007617","article-title":"Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice","volume":"15","author":"De Chiara","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2022.102200_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tins.2021.11.004","article-title":"Beneficial and detrimental functions of microglia during viral encephalitis","volume":"45","author":"Waltl","year":"2022","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.coph.2022.102200_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1242\/dmm.026674","article-title":"HSV presence in brains of individuals without dementia: the TASTY brain series","volume":"9","author":"Olsson","year":"2016","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.coph.2022.102200_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer's disease","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2022.102200_bib11","doi-asserted-by":"crossref","first-page":"e3637","DOI":"10.1371\/journal.pone.0003637","article-title":"Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study","volume":"3","author":"Letenneur","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2022.102200_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbrc.2012.12.054","article-title":"Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease","volume":"430","author":"Kobayashi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2022.102200_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/alz.12008","article-title":"Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease","volume":"16","author":"Linard","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.coph.2022.102200_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","article-title":"Multiscale Analysis of independent alzheimer's cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus","volume":"99","author":"Readhead","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2022.102200_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013989","article-title":"APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells","volume":"5","author":"De Chiara","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2022.102200_bib16","doi-asserted-by":"crossref","first-page":"2323 e2313","DOI":"10.1016\/j.neurobiolaging.2010.06.009","article-title":"HSV-1 promotes Ca2+ -mediated APP phosphorylation and Abeta accumulation in rat cortical neurons","volume":"32","author":"Piacentini","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.coph.2022.102200_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13365-015-0344-0","article-title":"Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer's disease pathogenesis","volume":"21","author":"Civitelli","year":"2015","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.coph.2022.102200_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fnagi.2016.00242","article-title":"Herpes simplex virus-type1 (HSV-1) impairs DNA repair in cortical neurons","volume":"8","author":"De Chiara","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.coph.2022.102200_bib19","doi-asserted-by":"crossref","first-page":"15444","DOI":"10.1038\/srep15444","article-title":"Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-beta protein accumulation","volume":"5","author":"Piacentini","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2022.102200_bib20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/stem.3072","article-title":"Herpes simplex virus type-1 infection impairs adult hippocampal neurogenesis via amyloid-beta protein accumulation","volume":"37","author":"Li Puma","year":"2019","journal-title":"Stem Cell"},{"key":"10.1016\/j.coph.2022.102200_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.coph.2022.102200_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2180-5-48","article-title":"Herpes simplex virus interferes with amyloid precursor protein processing","volume":"5","author":"Shipley","year":"2005","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.coph.2022.102200_bib23","doi-asserted-by":"crossref","first-page":"430 e419","DOI":"10.1016\/j.neurobiolaging.2010.12.010","article-title":"Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells","volume":"33","author":"Santana","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.coph.2022.102200_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01874-19","article-title":"Amyloid-beta and p-tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons","volume":"94","author":"Powell-Doherty","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.coph.2022.102200_sref25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay8828","article-title":"A\u00a03D human brain-like tissue model of herpes-induced Alzheimer's disease","volume":"6","author":"Cairns","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.coph.2022.102200_bib26","article-title":"Modeling herpes simplex virus 1 infections in human central nervous system neuronal cells using two- and three-dimensional cultures derived from induced pluripotent stem cells","volume":"93","author":"D'Aiuto","year":"2019","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.coph.2022.102200_bib27","article-title":"Modeling Abeta42 accumulation in response to herpes simplex virus 1 infection: 2D or 3D?","author":"Abrahamson","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.coph.2022.102200_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1","volume":"16","author":"Wozniak","year":"2009","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.coph.2022.102200_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jnr.23003","article-title":"Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells","volume":"90","author":"Alvarez","year":"2012","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.coph.2022.102200_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-131706","article-title":"Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation","volume":"39","author":"Martin","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.coph.2022.102200_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8070972","article-title":"Multiple herpes simplex virus-1 (HSV-1) reactivations induce protein oxidative damage in mouse brain: novel mechanisms for alzheimer's disease progression","volume":"8","author":"Protto","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.coph.2022.102200_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126279","article-title":"Recurrent herpes simplex virus type 1 (HSV-1) infection modulates neuronal aging marks in in\u00a0vitro and in\u00a0vivo models","volume":"22","author":"Napoletani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2022.102200_bib33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.neuron.2018.11.043","article-title":"Alzheimer's disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"100","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2022.102200_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2022.102200_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2022.102200_sref36","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1038\/s41467-019-10192-2","article-title":"The viral protein corona directs viral pathogenesis and amyloid aggregation","volume":"10","author":"Ezzat","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2022.102200_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coviro.2014.06.003","article-title":"Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance","volume":"8","author":"James","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coph.2022.102200_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.antiviral.2013.07.003","article-title":"The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1","volume":"99","author":"Wozniak","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.coph.2022.102200_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025152","article-title":"Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1","volume":"6","author":"Wozniak","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2022.102200_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections-a nationwide, population-based cohort study in taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.coph.2022.102200_bib41","doi-asserted-by":"crossref","first-page":"e12119","DOI":"10.1002\/trc2.12119","article-title":"Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden","volume":"7","author":"Lopatko Lindman","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.coph.2022.102200_bib42","doi-asserted-by":"crossref","first-page":"e1686","DOI":"10.1212\/WNL.0000000000010358","article-title":"A\u00a0nationwide, retrospective, data-linkage, cohort study of epilepsy and incident dementia","volume":"95","author":"Schnier","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2022.102200_bib43","article-title":"Antiviral treatment associated with reduced risk of clinical Alzheimer's disease-A nested case-control study","volume":"7","author":"Hemmingsson","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.coph.2022.102200_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1993.196","article-title":"Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers","volume":"54","author":"Weller","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2022.102200_bib45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dkh244","article-title":"Pharmacokinetics of valaciclovir","volume":"53","author":"MacDougall","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.coph.2022.102200_bib46","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/AAC.47.8.2438-2441.2003","article-title":"Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir","volume":"47","author":"Lycke","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2022.102200_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032112","article-title":"Antiviral therapy: valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial","volume":"10","author":"Devanand","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.coph.2022.102200_bib48","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1128\/AAC.01023-10","article-title":"Valacyclovir for herpes simplex encephalitis","volume":"55","author":"Pouplin","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2022.102200_bib49","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/AAC.00729-09","article-title":"Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function","volume":"54","author":"Smith","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2022.102200_bib50","doi-asserted-by":"crossref","first-page":"104755","DOI":"10.1016\/j.antiviral.2020.104755","article-title":"Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa","volume":"177","author":"Kim","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.coph.2022.102200_sref51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04106-w","article-title":"Herpesviruses assimilate kinesin to produce motorized viral particles","volume":"599","author":"Pegg","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coph.2022.102200_bib52","doi-asserted-by":"crossref","first-page":"23146","DOI":"10.1038\/srep23146","article-title":"Inhibition of HSV-1 replication by gene editing strategy","volume":"6","author":"Roehm","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2022.102200_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005701","article-title":"CRISPR\/Cas9-Mediated genome editing of herpesviruses limits productive and latent infections","volume":"12","author":"van Diemen","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2022.102200_sref54","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","article-title":"Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice","volume":"39","author":"Yin","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coph.2022.102200_bib55","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-020-17936-5","article-title":"Gene editing and elimination of latent herpes simplex virus in\u00a0vivo","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat Commun"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:54:44Z","timestamp":1761461684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489222000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":55,"alternative-id":["S1471489222000261"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2022.102200","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive\/therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2022.102200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102200"}}